These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 26312887)

  • 1. Effect of a GRIN2A de novo mutation associated with epilepsy and intellectual disability on NMDA receptor currents and Mg(2+) block in cultured primary cortical neurons.
    Marwick K; Skehel P; Hardingham G; Wyllie D
    Lancet; 2015 Feb; 385 Suppl 1():S65. PubMed ID: 26312887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The human NMDA receptor GluN2A
    Marwick KFM; Skehel PA; Hardingham GE; Wyllie DJA
    Pharmacol Res Perspect; 2019 Aug; 7(4):e00495. PubMed ID: 31249692
    [No Abstract]   [Full Text] [Related]  

  • 3. Functional assessment of triheteromeric NMDA receptors containing a human variant associated with epilepsy.
    Marwick KFM; Hansen KB; Skehel PA; Hardingham GE; Wyllie DJA
    J Physiol; 2019 Mar; 597(6):1691-1704. PubMed ID: 30604514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of GluN2A and GluN2B gain-of-function epilepsy mutations on synaptic currents mediated by diheteromeric and triheteromeric NMDA receptors.
    Chen X; Keramidas A; Harvey RJ; Lynch JW
    Neurobiol Dis; 2020 Jul; 140():104850. PubMed ID: 32247039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantification of the Mg2+-induced potency shift of amantadine and memantine voltage-dependent block in human recombinant GluN1/GluN2A NMDARs.
    Otton HJ; Lawson McLean A; Pannozzo MA; Davies CH; Wyllie DJ
    Neuropharmacology; 2011; 60(2-3):388-96. PubMed ID: 20955720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional assessment of the NMDA receptor variant GluN2A
    Marwick KFM; Parker P; Skehel P; Hardingham G; Wyllie DJA
    Wellcome Open Res; 2017 Mar; 2():20. PubMed ID: 28459106
    [No Abstract]   [Full Text] [Related]  

  • 7. Functional Properties of Human NMDA Receptors Associated with Epilepsy-Related Mutations of GluN2A Subunit.
    Sibarov DA; Bruneau N; Antonov SM; Szepetowski P; Burnashev N; Giniatullin R
    Front Cell Neurosci; 2017; 11():155. PubMed ID: 28611597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A de novo loss-of-function GRIN2A mutation associated with childhood focal epilepsy and acquired epileptic aphasia.
    Gao K; Tankovic A; Zhang Y; Kusumoto H; Zhang J; Chen W; XiangWei W; Shaulsky GH; Hu C; Traynelis SF; Yuan H; Jiang Y
    PLoS One; 2017; 12(2):e0170818. PubMed ID: 28182669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imprecision in Precision Medicine: Differential Response of a Disease-Linked GluN2A Mutant to NMDA Channel Blockers.
    Gale JR; Kosobucki GJ; Hartnett-Scott KA; Aizenman E
    Front Pharmacol; 2021; 12():773455. PubMed ID: 34776984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutations in GRIN2A and GRIN2B encoding regulatory subunits of NMDA receptors cause variable neurodevelopmental phenotypes.
    Endele S; Rosenberger G; Geider K; Popp B; Tamer C; Stefanova I; Milh M; Kortüm F; Fritsch A; Pientka FK; Hellenbroich Y; Kalscheuer VM; Kohlhase J; Moog U; Rappold G; Rauch A; Ropers HH; von Spiczak S; Tönnies H; Villeneuve N; Villard L; Zabel B; Zenker M; Laube B; Reis A; Wieczorek D; Van Maldergem L; Kutsche K
    Nat Genet; 2010 Nov; 42(11):1021-6. PubMed ID: 20890276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional Evaluation of a De Novo
    Chen W; Tankovic A; Burger PB; Kusumoto H; Traynelis SF; Yuan H
    Mol Pharmacol; 2017 Apr; 91(4):317-330. PubMed ID: 28126851
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Pierson TM; Yuan H; Marsh ED; Fuentes-Fajardo K; Adams DR; Markello T; Golas G; Simeonov DR; Holloman C; Tankovic A; Karamchandani MM; Schreiber JM; Mullikin JC; ; Tifft CJ; Toro C; Boerkoel CF; Traynelis SF; Gahl WA
    Ann Clin Transl Neurol; 2014 Mar; 1(3):190-198. PubMed ID: 24839611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel missense mutation in GRIN2A causes a nonepileptic neurodevelopmental disorder.
    Fernández-Marmiesse A; Kusumoto H; Rekarte S; Roca I; Zhang J; Myers SJ; Traynelis SF; Couce ML; Gutierrez-Solana L; Yuan H
    Mov Disord; 2018 Jul; 33(6):992-999. PubMed ID: 29644724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional Investigation of a GRIN2A Variant Associated with Rolandic Epilepsy.
    Xu XX; Liu XR; Fan CY; Lai JX; Shi YW; Yang W; Su T; Xu JY; Luo JH; Liao WP
    Neurosci Bull; 2018 Apr; 34(2):237-246. PubMed ID: 28936771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potency, voltage-dependency, agonist concentration-dependency, blocking kinetics and partial untrapping of the uncompetitive N-methyl-D-aspartate (NMDA) channel blocker memantine at human NMDA (GluN1/GluN2A) receptors.
    Gilling KE; Jatzke C; Hechenberger M; Parsons CG
    Neuropharmacology; 2009 Apr; 56(5):866-75. PubMed ID: 19371579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple effects of copper on NMDA receptor currents.
    Marchetti C; Baranowska-Bosiacka I; Gavazzo P
    Brain Res; 2014 Jan; 1542():20-31. PubMed ID: 24161827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Frameshift Variant of GluN2A Identified in an Epilepsy Patient Results in NMDA Receptor Mistargeting.
    Vieira MM; Peng S; Won S; Hong E; Inati SK; Thurm A; Thiam AH; Kim S; Myers SJ; Badger JD; Traynelis SF; Lu W; Roche KW
    J Neurosci; 2024 Jan; 44(4):. PubMed ID: 38050135
    [No Abstract]   [Full Text] [Related]  

  • 18. Common synaptic phenotypes arising from diverse mutations in the human NMDA receptor subunit GluN2A.
    Elmasri M; Hunter DW; Winchester G; Bates EE; Aziz W; Van Der Does DM; Karachaliou E; Sakimura K; Penn AC
    Commun Biol; 2022 Feb; 5(1):174. PubMed ID: 35228668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of Plasma Membrane Na/Ca-Exchanger by KB-R7943 or Lithium Reveals Its Role in Ca-Dependent N-methyl-d-aspartate Receptor Inactivation.
    Sibarov DA; Abushik PA; Poguzhelskaya EE; Bolshakov KV; Antonov SM
    J Pharmacol Exp Ther; 2015 Dec; 355(3):484-95. PubMed ID: 26391160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GRIN1 mutation associated with intellectual disability alters NMDA receptor trafficking and function.
    Chen W; Shieh C; Swanger SA; Tankovic A; Au M; McGuire M; Tagliati M; Graham JM; Madan-Khetarpal S; Traynelis SF; Yuan H; Pierson TM
    J Hum Genet; 2017 Jun; 62(6):589-597. PubMed ID: 28228639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.